A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
Condition: Healthy Intervention: Drug: sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-07275315; Drug: PF-07264660; Other: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
Condition: Healthy Intervention: Drug: sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-07275315; Drug: PF-07264660; Other: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
Condition: Healthy Intervention: Drug: sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-07275315; Drug: PF-07264660; Other: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
Condition: Healthy Intervention: Drug: sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-07275315; Drug: PF-07264660; Other: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
Condition: Healthy Intervention: Drug: sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-07275315; Drug: PF-07264660; Other: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
Condition: Migraine Interventions: Drug: Zavegepant; Drug: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.
Condition: Respiratory Syncytial Virus Infection Intervention: Drug: Sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
Condition: Migraine Interventions: Drug: Zavegepant; Drug: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.
Condition: Respiratory Syncytial Virus Infection Intervention: Drug: Sisunatovir Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
Condition: Migraine Interventions: Drug: Zavegepant; Drug: Placebo Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
